Treatment of Sebaceous Hyperplasia by Laser Modalities: A Review of the Literature and Presentation of Our Experience With Erbium-doped Yttrium Aluminium Garnet (Er:YAG)
| Autor: | Annie Liu, Mark B Taylor, Bahman Sotoodian |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male Treatment response medicine.medical_specialty Side effect Lasers Dye Sebaceous hyperplasia chemistry.chemical_element Lasers Solid-State Excimer law.invention Erbium Sebaceous Glands chemistry.chemical_compound Recurrence law Yttrium aluminium garnet medicine Humans Aged Retrospective Studies Hyperplasia Dye laser business.industry General Medicine Middle Aged Sebaceous Gland Diseases medicine.disease Laser Dermatology Treatment Outcome chemistry Erythema Female business |
| Zdroj: | Journal of Drugs in Dermatology. 19:547-552 |
| ISSN: | 1545-9616 |
| Popis: | Introduction Sebaceous hyperplasia (SH) is a common skin presentation in adults. Due to their unwanted yellow papular appearance, patients may desire their removal. Although several treatment modalities have been reported, the full range and efficacy of options are unclear. Objective To determine the efficacy of laser modalities in the treatment of SH. The authors will also specifically assess the efficacy, recurrence rate and side effect profile of SH treatment with Er:YAG wavelength using a variable long pulsed (VLP) Er:YAG laser (SP Dynamis Fotona laser, Ljubljana, Slovenia) Methods a Materials: A comprehensive literature search was performed through PubMed, EMBASE, and Web of Science, using the search terms [(sebaceous hyperplasia)] and [(laser[s], Er:Yag, Er:Glass, Fraxel, CO2, PDL, Pulse dye laser, Diode, Xe-Cl, Excimer, Argon, KTP, Ruby, Alexandrite or Nd:YAG)]. The search yielded a total of 119 results and 8 were identified as relevant to this reviewResults: Pulse dye laser (PDL) provides a wide range of treatment results from complete reduction to flattening of the SH without significant adverse events; recurrence rates were unreported. Short PDL showed faster treatment response than long PDL. CO2 laser can produce considerable positive cosmetic outcomes with marked clinical improvement without any recurrence, but significant adverse effects have been reported. The 1450-nm diode laser has been described to produce good (75%) clinical improvement and lesion shrinkage ranging from 50% to greater than 75% without lasting adverse effects. In our clinic, Er:YAG has provided very significant cosmetic outcomes with a low recurrence rate and minimal adverse effects. Conclusions Laser modalities can provide satisfactory results for removing SH. It is crucial that the laser is being used by an expert who is familiar with the device as well as understand the laser tissue interaction to minimize patient adverse effects while providing the best cosmetic outcome. In our experience, Er:YAG laser can provide a safe and highly effective solution for SH. J Drugs Dermatol. 2020;19(5) n doi:10.36849/JDD.2020.3971. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|